Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Kerwin, RW' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 123 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sodhi, MS; Burnet, PWJ; Makoff, AJ; Kerwin, RW; Harrison, PJ
      RNA editing of the 5-HT2C receptor is reduced in schizophrenia

      MOLECULAR PSYCHIATRY
    2. Arranz, MJ; Mancama, D; Kerwin, RW
      Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    3. Collier, DA; Osborne, S; Munro, J; Kerwin, RW
      Pharmacogenetic methods in schizophrenia

      INTERNATIONAL REVIEW OF PSYCHIATRY
    4. Bolonna, AA; Kerwin, RW; Munro, J; Arranz, MJ; Makoff, AJ
      Polymorphisms in the genes for mGluR types 7 and 8: association studies with schizophrenia

      SCHIZOPHRENIA RESEARCH
    5. Pariante, CM; Makoff, A; Lovestone, S; Feroli, S; Heyden, A; Miller, AH; Kerwin, RW
      Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters

      BRITISH JOURNAL OF PHARMACOLOGY
    6. Arranz, MJ; Bolonna, AA; Munro, J; Curtis, CJ; Collier, DA; Kerwin, RW
      The serotonin transporter and clozapine response

      MOLECULAR PSYCHIATRY
    7. Aitchison, KJ; Gonzalez, FJ; Quattrochi, LC; Sapone, A; Zhao, JH; Zaher, H; Elizondo, G; Bryant, C; Munro, J; Collier, DA; Makoff, AJ; Kerwin, RW
      Identification of novel polymorphisms in the 5 ' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance

      PHARMACOGENETICS
    8. Birkett, JT; Arranz, MJ; Munro, J; Osbourn, S; Kerwin, RW; Collier, DA
      Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response

      NEUROREPORT
    9. Arranz, MJ; Kerwin, RW
      Neurotransmitter-related genes and antipsychotic response: pharmacogenetics meets psychiatric treatment

      ANNALS OF MEDICINE
    10. Bolonna, AA; Arranz, MJ; Munro, J; Osborne, S; Petouni, M; Martinez, M; Kerwin, RW
      No influence of adrenergic receptor polymorphisms on schizophrenia and antipsychotic response

      NEUROSCIENCE LETTERS
    11. Aitchison, KJ; Jann, MW; Zhao, JH; Sakai, T; Zaher, H; Wolff, K; Collier, DA; Kerwin, RW; Gonzalez, FJ
      Clozapine pharmacokinetics and pharmacodynamics studied with CYP1A2-null mice

      JOURNAL OF PSYCHOPHARMACOLOGY
    12. Bell, R; Munro, J; Russ, C; Powell, JF; Bruinvels, A; Kerwin, RW; Collier, DA
      Systematic screening of the 14-3-3 eta (eta) chain gene for polymorphic variants and case-control analysis in schizophrenia

      AMERICAN JOURNAL OF MEDICAL GENETICS
    13. Lingford-Hughes, AR; Acton, PD; Gacinovic, S; Boddington, SJA; Costa, DC; Pilowsky, LS; Ell, PJ; Marshall, EJ; Kerwin, RW
      Levels of gamma-aminobutyric acid-benzodiazepine receptors in abstinent, alcohol-dependent women: Preliminary findings from an I-123-iomazenil singlephoton emission tomography study

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    14. Arranz, MJ; Munro, J; Osborne, S; Collier, D; Kerwin, RW
      Difficulties in replication of results

      LANCET
    15. Arranz, MJ; Munro, J; Birkett, J; Bolonna, A; Mancama, D; Sodhi, M; Lesch, KP; Meyer, JFW; Sham, P; Collier, DA; Murray, RM; Kerwin, RW
      Pharmacogenetic prediction of clozapine response

      LANCET
    16. Stephenson, CME; Bigliani, V; Jones, HM; Mulligan, RS; Acton, PD; Visvikis, D; Ell, PJ; Kerwin, RW; Pilowsky, LS
      Striatal and extra-striatal D-2/D-3 dopamine receptor occupancy by quetiapine in vivo - [I-123]-epidepride single photon emission tomography (SPET) study

      BRITISH JOURNAL OF PSYCHIATRY
    17. Jones, HM; Travis, MJ; Mulligan, R; Visvikis, D; Gacinovic, S; Ell, PJ; Kerwin, RW; Pilowsky, LS
      In vivo serotonin 5-HT2A receptor occupancy and quetiapine

      AMERICAN JOURNAL OF PSYCHIATRY
    18. Bigliani, V; Mulligan, RS; Acton, PD; Ohlsen, RI; Pike, VW; Ell, PJ; Gacinovic, S; Kerwin, RW; Pilowsky, LS
      Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [I-123]epidepride single photon emission tomography (SPET) study

      PSYCHOPHARMACOLOGY
    19. Aitchison, KJ; Munro, J; Wright, P; Smith, S; Makoff, AJ; Sachse, C; Sham, PC; Murray, RM; Collier, DA; Kerwin, RW
      Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    20. Bigliani, V; Mulligan, RS; Acton, PD; Visvikis, D; Ell, PJ; Stephenson, C; Kerwin, RW; Pilowsky, LS
      In vivo occupancy of striatal and temporal cortical D-2/D-3 dopamine receptors by typical antipsychotic drugs - [I-123]-epidepride single photon emission tomography (SPET) study

      BRITISH JOURNAL OF PSYCHIATRY
    21. ARRANZ MJ; MUNRO J; OWEN MJ; SPURLOCK G; SHAM PC; ZHAO J; KIROV G; COLLIER DA; KERWIN RW
      EVIDENCE FOR ASSOCIATION BETWEEN POLYMORPHISMS IN THE PROMOTER AND CODING REGIONS OF THE 5-HT2A RECEPTOR GENE AND RESPONSE TO CLOZAPINE

      Molecular psychiatry
    22. Arranz, MJ; Li, T; Munro, J; Liu, X; Murray, R; Collier, DA; Kerwin, RW
      Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine response

      PHARMACOGENETICS
    23. LI T; ARRANZ M; AITCHISON KJ; BRYANT C; LIU XH; KERWIN RW; MURRAY R; SHAM P; COLLIER DA
      CASE-CONTROL, HAPLOTYPE RELATIVE RISK AND TRANSMISSION DISEQUILIBRIUMANALYSIS OF A DOPAMINE D2 RECEPTOR FUNCTIONAL PROMOTER POLYMORPHISM IN SCHIZOPHRENIA

      Schizophrenia research
    24. EVERALL IP; COTTER DC; HONAVAR M; ANDERTON B; KERWIN RW
      THE ROLE OF CATENINS AND ADENOMATOUS POLYPOSIS-COLI (APC) IN NEURODEVELOPMENT - ABNORMALITIES IN FOCAL CORTICAL DYSPLASIA

      Schizophrenia research
    25. ARRANZ MJ; MUNRO J; COLLIER DA; KIROV G; KERWIN RW
      GENETIC-VARIATION IN THE 5-HT3 RECEPTOR GENE - NO ASSOCIATION WITH SCHIZOPHRENIA OR DRUG RESPONSE

      Schizophrenia research
    26. ARRANZ MJ; MUNRO J; COLLIER DA; KROV G; SHAM P; ZHAO J; KERWIN RW
      FURTHER EVIDENCE FOR ASSOCIATION BETWEEN POLYMORPHISMS IN THE 5-HT2A RECEPTOR GENE AND CLOZAPINE RESPONSE

      Schizophrenia research
    27. ARRANZ MJ; MUNRO J; LI T; COLLIER DA; KIROV G; KERWIN RW
      A POLYMORPHISM IN THE PROMOTER REGION OF THE DOPAMINE D2 RECEPTOR GENE (DRD2) AND DRUG RESPONSE - ASSOCIATION STUDIES

      Schizophrenia research
    28. BIRKETT JTP; COLLIER DA; KERWIN RW
      A 2ND NOVEL POLYMORPHISM IN THE PROMOTOR REGION OF THE N-ACETYLTRANSFERASE GENE (AA-NAT) IS NOT ASSOCIATED WITH SCHIZOPHRENIA OR BIPOLAR AFFECTIVE-DISORDER

      Schizophrenia research
    29. BOLONNA AA; MAKOFF AJ; COLLIER DA; ARRANZ MJ; KERWIN RW
      THE NMDAR1 RECEPTOR GENE AND SCHIZOPHRENIA

      Schizophrenia research
    30. BIGLIANI V; MULLIGAN RS; ACTON PD; GACINOVIC S; ELL PJ; KERWIN RW; PILOWSKY LS
      DIFFERENT PATTERNS OF D-2 D-2-LIKE RECEPTOR BLOCKADE IN THE TEMPORAL CORTEX AND THE STRIATUM BY TYPICAL ANTIPSYCHOTICS - AN I-123 EPIDEPRIDE SPET STUDY/

      Schizophrenia research
    31. TRAVIS MJ; BUSATTO GF; PILOWSKY LS; MULLIGAN R; GACINOVIC S; ACTON PD; COSTA DC; MERTENS J; TERRIERE D; ELL PJ; KERWIN RW
      TYPICAL ANTIPSYCHOTICS LEAD TO 5-HT2A RECEPTOR BLOCKADE IN-VIVO IN SCHIZOPHRENIC-PATIENTS - INITIAL SINGLE-PHOTON EMISSION TOMOGRAPHY (SPET) FINDINGS

      Schizophrenia research
    32. STEFANIS NC; BRESNICK JN; KERWIN RW; SCHOFIELD WN; MCALLISTER G
      ELEVATION OF D-4 DOPAMINE-RECEPTOR MESSENGER-RNA IN POSTMORTEM SCHIZOPHRENIC BRAIN

      Molecular brain research
    33. BIGLIANI V; MULLIGAN RS; ACTON PD; STEPHENSON C; GACINOVIC S; ELL PJ; KERWIN RW; PILOWSKY LS
      PRELIMINARY-RESULTS - D-2 D-2-LIKE RECEPTOR-BINDING IN TEMPORAL CORTEX AND STRIATUM IN SERTINDOLE AND OLANZAPINE TREATED PATIENTS/

      The Journal of nuclear medicine
    34. TRAVIS MJ; BUSATTO GF; PILOWSKY LS; MULLIGAN RS; GACINOVIC S; ACTON PD; COSTA DC; ELL PJ; KERWIN RW
      BROAD-SPECTRUM TYPICAL ANTIPSYCHOTICS AND IN-VIVO 5-HT2A RECEPTOR OCCUPANCY IN SCHIZOPHRENIC-PATIENTS - SPET FINDINGS

      The Journal of nuclear medicine
    35. LINGFORDHUGHES AR; ACTON PD; GACINOVIC S; SUCKLING J; BUSATTO GF; PILOWSKY LS; COSTA DC; BULLMORE E; WOODRUFF P; BODDINGTON S; ELL PJ; MARSHALL EJ; KERWIN RW
      GENDER DIFFERENCES IN THE PATTERN OF REDUCED LEVELS OF THE GABA BENZODIAZEPINE RECEPTOR IN ALCOHOL DEPENDENCY - AN L23 I-IOMAZENIL SPECT AND MRI STUDY

      The Journal of nuclear medicine
    36. BIRKETT JTP; KIROV G; POWELL J; MURRAY RM; KERWIN RW; COLLIER DA
      NO ASSOCIATION BETWEEN A VARIABLE NUMBER OF TANDEM REPEAT (VNTR) IN THE 3'-UNTRANSLATED REGION OF THE DOPAMINE TRANSPORTER GENE (DAT1) AND BIPOLAR AFFECTIVE-DISORDER

      American journal of medical genetics
    37. KALKMAN HO; CHARARA N; KUNTZELMANN G; MUNRO J; KERWIN RW; LOETSCHER E
      STRUCTURAL POLYMORPHISM IN THE ALPHA(2B) ADRENOCEPTOR - NO ASSOCIATION WITH SCHIZOPHRENIA OR CLOZAPINE RESPONSIVENESS

      American journal of medical genetics
    38. BIRKETT JTP; BALL D; KERWIN RW; COLLIER DA
      NO ASSOCIATION BETWEEN 2 PROMOTOR POLYMORPHISMS OF THE HUMAN N-ACETYLTRANSFERASE GENE (AA-NAT) AND ALZHEIMERS-DISEASE

      American journal of medical genetics
    39. LINGFORDHUGHES AR; ACTON PD; GACINOVIC S; SUCKLING J; BUSATTO GF; BODDINGTON SJA; BULLMORE E; WOODRUFF PW; COSTA DC; PILOWSKY LS; ELL PJ; MARSHALL EJ; KERWIN RW
      REDUCED LEVELS OF GABA-BENZODIAZEPINE RECEPTOR IN ALCOHOL DEPENDENCY IN THE ABSENCE OF GREY-MATTER ATROPHY

      British Journal of Psychiatry
    40. TRAVIS MJ; BUSATTO GF; PILOWSKY LS; MULLIGAN R; ACTON PD; GACINOVIC S; MERTENS J; TERRIERE D; COSTA DC; ELL PJ; KERWIN RW
      5-HT2A RECEPTOR BLOCKADE IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH RISPERIDONE OR CLOZAPINE - A SPET STUDY USING THE NOVEL 5-HT2A LIGAND I-123 5-I-R-91150

      British Journal of Psychiatry
    41. BALL S; BUSATTO GF; DAVID AS; JONES SH; HEMSLEY DR; PILOWSKY LS; COSTA DC; ELL PJ; KERWIN RW
      COGNITIVE-FUNCTIONING AND GABA(A) BENZODIAZEPINE RECEPTOR-BINDING IN SCHIZOPHRENIA - A I-123 IOMAZENIL SPET STUDY/

      Biological psychiatry
    42. LUCEY JV; COSTA DC; BUSATTO G; PILOWSKY LS; MARKS IM; ELL PJ; KERWIN RW
      CAUDATE REGIONAL CEREBRAL BLOOD-FLOW IN OBSESSIVE-COMPULSIVE DISORDER, PANIC DISORDER AND HEALTHY CONTROLS ON SINGLE-PHOTON EMISSION COMPUTERIZED-TOMOGRAPHY

      PSYCHIATRY RESEARCH-NEUROIMAGING
    43. COTTER DR; DOSHI B; KERWIN RW; EVERALL IP
      LATERALIZED ALTERATIONS IN HIPPOCAMPAL MAP2 IN SCHIZOPHRENIA

      Schizophrenia research
    44. AITCHISON KJ; MUNRO J; WRIGHT P; CHAPMAN S; COLLIER DA; KERWIN RW
      PHARMACOGENETIC FACTORS IN TREATMENT-RESISTANT SCHIZOPHRENIA - THE ROLE OF CYP2D6 VARIANTS

      Schizophrenia research
    45. SODHI MS; KIROV G; AITCHISON KJ; ARRANZ MJ; COLLIER DA; KERWIN RW
      ALLELIC VARIATION OF THE 5-HT2C RECEPTOR IN PSYCHOSIS

      Schizophrenia research
    46. BIRKETT JTP; COLLIER DA; MUNRO J; ARRANZ MJ; ROBERTS GW; PRICE J; KERWIN RW
      NO ASSOCIATION BETWEEN A NOVEL POLYMORPHISM IN THE 5-HT4 RECEPTOR GENE AND RESPONSE TO CLOZAPINE

      Schizophrenia research
    47. BOLONNA AA; MAKOFF AJ; COLLIER DA; KIROV G; MUNRO J; ARRANZ MJ; KERWIN RW
      AN INVESTIGATION OF THE GLUR6 RECEPTOR GENE (GRIK2) IN SCHIZOPHRENIA

      Schizophrenia research
    48. ROYSTON MC; BELL R; COLLIER D; KERWIN RW; ROBERTS GW
      APOLIPOPROTEIN-E AND SCHIZOPHRENIA - ASSOCIATION WITH CLINICAL-RESPONSE TO CLOZAPINE

      Schizophrenia research
    49. BUSATTO GF; TRAVIS MJ; PILOWSKY LS; COSTA DC; MULLIGAN R; MERTENS J; TERRIERE D; ELL PJ; ACTON P; GACINOVIC S; OKOCHA C; LEYSEN JE; KERWIN RW
      5-HT2A RECEPTOR BLOCKADE IN-VIVO IN SCHIZOPHRENIC-PATIENTS TREATED WITH ATYPICAL ANTIPSYCHOTICS - SINGLE-PHOTON EMISSION TOMOGRAPHY (SPET) FINDINGS

      Schizophrenia research
    50. PILOWSKY LS; OCONNELL P; DAVIES N; BUSATTO GF; COSTA DC; ELL PJ; KERWIN RW
      A 123I IBZM SPET STUDY OF STRIATAL D2 RECEPTORS IN SERTINDOLE TREATEDPATIENTS

      Schizophrenia research
    51. PILOWSKY LS; BUSATTO GF; TAYLOR M; COSTA DC; SHARMA T; SIGMUNDSSEN T; ELL PJ; NOHRIA V; KERWIN RW
      STRIATAL D2 RECEPTOR-BINDING IN OLANZAPINE TREATED PATIENTS ESTIMATEDBY 123I IBZM SPET (SINGLE-PHOTON EMISSION TOMOGRAPHY)

      Schizophrenia research
    52. PILOWSKY LS; MULLIGAN RS; ACTON PD; GACINOVIC S; BUSATTO GF; KESSLER RM; ELL PJ; TRAVIS MJ; BIGLIANI V; STEPHENSON C; COSTA DC; KERWIN RW
      PRELIMINARY-REPORT - EFFECTS OF CLOZAPINE AND TYPICAL ANTIPSYCHOTICS ON STRIATAL AND LIMBIC DOPAMINE D2 D2-LIKE RECEPTORS IN-VIVO BY 123I EPIDEPRIDE SPET/

      Schizophrenia research
    53. AITCHISON KJ; MUNRO J; WRIGHT P; CHAPMAN S; MAKOFF AJ; COLLIER DA; KERWIN RW
      PHARMACOGENETIC FACTORS IN TREATMENT-RESISTANT SCHIZOPHRENIA - THE ROLE OF CYP2D6 VARIANTS

      The FASEB journal
    54. BUSATTO GF; PILOWSKY LS; COSTA DC; MERTENS J; TERRIERE D; ELL PJ; MULLIGAN R; TRAVIS MJ; LEYSEN JE; LUI D; GACINOVIC S; WADDINGTON W; LINGFORDHUGHES A; KERWIN RW
      INITIAL EVALUATION OF I-123 5-I-R91150, A SELECTIVE 5-HT2A LIGAND FORSINGLE-PHOTON EMISSION TOMOGRAPHY, IN HEALTHY-HUMAN SUBJECTS (VOL 24,PG 119, 1997)

      European journal of nuclear medicine
    55. BUSATTO GF; PILOWSKY LS; COSTA DC; MERTENS J; TERRIERE D; ELL PJ; MULLIGAN R; TRAVIS MJ; LEYSEN JE; LUI D; GACINOVIC S; WADDINGTON W; LINGFORDHUGHES A; KERWIN RW
      INITIAL EVALUATION OF I-123 5-I-R91150, A SELECTIVE 5-HT2A LIGAND FORSINGLE-PHOTON EMISSION TOMOGRAPHY, IN HEALTHY-HUMAN SUBJECTS

      European journal of nuclear medicine
    56. MULCRONE J; KERWIN RW
      THE REGIONAL PATTERN OF D4 GENE-EXPRESSION IN HUMAN BRAIN

      Neuroscience letters
    57. EVERALL IP; HUDSON L; KERWIN RW
      DECREASED ABSOLUTE LEVELS OF ASCORBIC-ACID AND UNALTERED VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR-BINDING IN THE FRONTAL-CORTEX IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME

      Neuroscience letters
    58. BUSATTO GF; KERWIN RW
      PERSPECTIVES ON THE ROLE OF SEROTONERGIC MECHANISMS IN THE PHARMACOLOGY OF SCHIZOPHRENIA

      JOURNAL OF PSYCHOPHARMACOLOGY
    59. BUSATTO GF; KERWIN RW
      REPLY TO COMMENTARIES

      JOURNAL OF PSYCHOPHARMACOLOGY
    60. BUSATTO GF; KERWIN RW
      SCHIZOPHRENIA, PSYCHOSIS, AND THE BASAL GANGLIA

      The Psychiatric clinics of North America
    61. PILOWSKY LS; MULLIGAN RS; ACTON PD; GACINOVIC S; BUSATTO GF; KESSLER RM; ELL PJ; TRAVIS MJ; BIGLIANI V; STEPHENSON C; COSTA DC; KERWIN RW
      CLOZAPINE SHOWS SELECTIVE OCCUPANCY OF EXTRA-STRIATAL DOPAMINE D2 D2-LIKE RECEPTORS - A 1231-EPIDEPRIDE SPET STUDY - PRELIMINARY FINDINGS

      The Journal of nuclear medicine
    62. TRAVIS MJ; BUSATTO GF; PILOWSKY LS; MULLIGAN R; GACINOVIC S; ACTON P; COSTA DC; MERTENS J; TERRIERE D; ELL PJ; BIGLIANI V; OKOCHA C; KERWIN RW
      IN-VIVO 5-HT2A RECEPTOR BLOCKADE IN SCHIZOPHRENIC-PATIENTS TREATED WITH THE BROAD-SPECTRUM ATYPICAL ANTIPSYCHOTICS CLOZAPINE AND OLANZAPINE- PRELIMINARY SPET FINDINGS

      The Journal of nuclear medicine
    63. LINGFORDHUGHES AR; ACTON PD; GACINOVIC S; BUSATTO GF; COSTA DC; BODDINGTON S; MARSHALL JE; ELL PJ; KERWIN RW; PILOWSKY LS
      REDUCED LEVELS OF THE GABA BENZODIAZEPINE RECEPTOR IN ALCOHOL DEPENDENCY - AN 123I-IOMAZENIL SPET STUDY

      The Journal of nuclear medicine
    64. ARRANZ MJ; MUNRO J; OWEN MJ; SPURLOCK G; SHAM PC; ZHAO J; KIROV G; COLLIER DA; KERWIN RW
      EVIDENCE FOR ASSOCIATION BETWEEN POLYMORPHISMS IN THE PROMOTER AND CODING REGIONS OF THE 5-HT2A RECEPTOR GENE AND RESPONSE TO CLOZAPINE

      American journal of medical genetics
    65. ARRANZ MJ; MUNRO J; KIROV G; KERWIN RW; COLLIER DA
      NOVEL POLYMORPHISMS DETECTED IN THE 5-HT3 RECEPTOR GENE - ASSOCIATIONSTUDIES WITH SCHIZOPHRENIA AND CLOZAPINE RESPONSE

      American journal of medical genetics
    66. BOLONNA AA; MAKOFF AJ; COLLIER DA; KIROV G; ARRANZ MJ; KERWIN RW
      ANALYSIS OF THE NMDA RECEPTOR IN SCHIZOPHRENIA

      American journal of medical genetics
    67. AITCHISON KJ; MUNRO J; WRIGHT P; CHAPMAN S; SODHI MS; MAKOFF AJ; COLLIER DA; KERWIN RW
      PHARMACOGENETIC FACTORS IN TREATMENT-RESISTANT SCHIZOPHRENIA - THE ROLE OF CYP2D6 VARIANTS

      American journal of medical genetics
    68. BELL R; COLLIER DA; RICE SJ; ROBERTS GW; MACPHEE CH; KERWIN RW; PRICE J; GLOGER IS
      SYSTEMATIC SCREENING OF THE LDL-PLA(2) GENE FOR POLYMORPHIC VARIANTS AND CASE-CONTROL ANALYSIS IN SCHIZOPHRENIA

      American journal of medical genetics
    69. BIRKETT JTP; COLLIER DA; KERWIN RW
      A NOVEL POLYMORPHISM IN THE PROMOTER REGION OF THE N-ACETYLTRANSFERASE GENE IS NOT ASSOCIATED WITH SCHIZOPHRENIA OR BIPOLAR AFFECTIVE-DISORDER

      American journal of medical genetics
    70. BIRKETT JTP; COLLIER DA; KERWIN RW
      A NOVEL POLYMORPHISM IN THE PROMOTER REGION OF THE N-ACETYLTRANSFERASE GENE IS NOT ASSOCIATED WITH SCHIZOPHRENIA OR BIPOLAR AFFECTIVE-DISORDER

      American journal of medical genetics
    71. PILOWSKY LS; MULLIGAN RS; ACTON PD; ELL PJ; COSTA DC; KERWIN RW
      LIMBIC SELECTIVITY OF CLOZAPINE

      Lancet
    72. AITCHISON KJ; KERWIN RW
      COST-EFFECTIVENESS OF CLOZAPINE - A UK CLINIC-BASED STUDY

      British Journal of Psychiatry
    73. TRAVIS MJ; BUSATTO GF; PILOWSKY LS; KERWIN RW; MULLIGAN R; GACINOVIC S; COSTA DC; ELL PJ; MERTENS J; TERRIERE D
      SEROTONIN - 5-HT2A RECEPTOR OCCUPANCY IN-VIVO AND RESPONSE TO THE NEWANTIPSYCHOTICS OLANZAPINE AND SERTINDOLE

      British Journal of Psychiatry
    74. LUCEY JV; COSTA DC; ADSHEAD G; DEAHL M; BUSATTO G; GACINOVIC S; TRAVIS M; PILOWSKY L; ELL PJ; MARKS IM; KERWIN RW
      BRAIN BLOOD-FLOW IN ANXIETY DISORDERS - OCD, PANIC DISORDER WITH AGORAPHOBIA, AND POSTTRAUMATIC-STRESS-DISORDER ON 99MTCHMPAO SINGLE-PHOTONEMISSION TOMOGRAPHY (SPET)

      British Journal of Psychiatry
    75. KERWIN RW; AITCHISON KJ
      COST-EFFECTIVENESS OF CLOZAPINE

      British Journal of Psychiatry
    76. LUCEY JV; BURNESS CE; COSTA DC; GACINOVIC S; PILOWSKY LS; ELL PJ; MARKS IM; KERWIN RW
      WISCONSIN CARD SORTING TASK (WCST) ERRORS AND CEREBRAL BLOOD-FLOW IN OBSESSIVE-COMPULSIVE DISORDER (OCD)

      British Journal of Medical Psychology
    77. EASTWOOD SL; KERWIN RW; HARRISON PJ
      IMMUNOAUTORADIOGRAPHIC EVIDENCE FOR A LOSS OF ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLE PROPIONATE-PREFERRING NON-N-METHYL-D-ASPARTATE GLUTAMATE RECEPTORS WITHIN THE MEDIAL TEMPORAL-LOBE IN SCHIZOPHRENIA

      Biological psychiatry
    78. BELL R; COLLIER DA; RICE SQJ; ROBERTS GW; MACPHEE CH; KERWIN RW; PRICE J; GLOGER IS
      SYSTEMATIC SCREENING OF THE LDL-PLA(2) GENE FOR POLYMORPHIC VARIANTS AND CASE-CONTROL ANALYSIS IN SCHIZOPHRENIA

      Biochemical and biophysical research communications
    79. BUSATTO GF; PILOWSKY LS; KERWIN RW; ELL PJ
      BENZODIAZEPINE RECEPTOR-BINDING AND SCHIZOPHRENIA - REPLY

      The American journal of psychiatry
    80. BUSATTO GF; PILOWSKY LS; COSTA DC; ELL PJ; DAVID AS; LUCY JV; KERWIN RW
      CORRELATION BETWEEN REDUCED IN-VIVO BENZODIAZEPINE RECEPTOR-BINDING AND SEVERITY OF PSYCHOTIC SYMPTOMS IN SCHIZOPHRENIA

      The American journal of psychiatry
    81. PILOWSKY LS; OCONNELL P; DAVIES N; BUSATTO GF; COSTA DC; MURRAY RM; ELL PJ; KERWIN RW
      IN-VIVO EFFECTS ON STRIATAL DOPAMINE D-2 RECEPTOR-BINDING BY THE NOVEL ATYPICAL ANTIPSYCHOTIC DRUG SERTINDOLE - A I-123 IBZM SINGLE-PHOTON EMISSION TOMOGRAPHY (SPET) STUDY

      Psychopharmacology
    82. ARRANZ MJ; KIROV G; SODHI MS; BALL DM; KERWIN RW; COLLIER DA
      5-HT2A POLYMORPHISMS AND MENTAL-DISORDERS

      Schizophrenia research
    83. EASTWOOD SL; PORTER RHP; BURNET PWJ; KERWIN RW; HARRISON PJ
      NON-NMDA GLUTAMATE-RECEPTOR EXPRESSION IN SCHIZOPHRENIA

      Schizophrenia research
    84. SODHI MS; KIROV G; ARRANZ MJ; BALL DM; AITCHISON KJ; KERWIN RW; COLLIER DA
      ASSOCIATION BETWEEN PSYCHOSES AND ALLELIC VARIATION IN THE 5-HT2C RECEPTOR GENE

      Schizophrenia research
    85. SODHI MS; ARRANZ MJ; BALL DM; ROBERTS GW; PRICE J; COLLIER DA; KERWIN RW
      ASSOCIATION BETWEEN CLOZAPINE RESPONSE AND ALLELIC VARIATION IN THE 5-HT2A AND 5-HT2C RECEPTOR GENES

      Schizophrenia research
    86. AITCHISON KJ; PATEL M; TAYLOR M; MURRAY RM; ARRANZ MJ; COLLIER DA; KERWIN RW
      NEUROLEPTIC SENSITIVITY AND ENZYME DEFICIENCY IN 2 SCHIZOPHRENIC BROTHERS - A CASE-REPORT

      Schizophrenia research
    87. SHAIKH S; COLLIER DA; SHAM PC; BALL D; AITCHISON K; VALLADA H; SMITH I; GILL M; KERWIN RW
      ALLELIC ASSOCIATION BETWEEN A SER-9-GLY POLYMORPHISM IN THE DOPAMINE D3 RECEPTOR GENE AND SCHIZOPHRENIA

      Human genetics
    88. MULCRONE J; KERWIN RW
      NO DIFFERENCE IN THE EXPRESSION OF THE D4 GENE IN POSTMORTEM FRONTAL-CORTEX FROM CONTROLS AND SCHIZOPHRENICS

      Neuroscience letters
    89. ARRANZ MJ; COLLIER DA; MUNRO J; SHAM P; KIROV G; SODHI M; ROBERTS G; PRICE J; KERWIN RW
      ANALYSIS OF A STRUCTURAL POLYMORPHISM IN THE 5-HT2A RECEPTOR AND CLINICAL-RESPONSE TO CLOZAPINE

      Neuroscience letters
    90. KERWIN RW; COLLIER D
      THE DOPAMINE D4 RECEPTOR IN SCHIZOPHRENIA - AN UPDATE

      Psychological medicine
    91. PILOWSKY LS; BUSATTO GF; TAYLOR M; COSTA DC; SHARMA T; SIGMUNDSSON T; ELL PJ; NOHRIA V; KERWIN RW
      STRIATAL DOPAMINE D-2 RECEPTOR-BINDING ESTIMATED IN-VIVO IN OLANZAPINE-TREATED SCHIZOPHRENIC-PATIENTS BY I-123 IBZM SINGLE-PHOTON EMISSION TOMOGRAPHY (SPET)

      British Journal of Pharmacology
    92. PILOWSKY LS; BUSATTO GF; TAYLOR M; COSTA DC; SHARMA T; SIGMUNDSSON T; ELL PJ; NOHRIA V; KERWIN RW
      DOPAMINE D-2 RECEPTOR OCCUPANCY IN-VIVO BY THE NOVEL ATYPICAL ANTIPSYCHOTIC OLANZAPINE - A I-123 IBZM SINGLE-PHOTON EMISSION TOMOGRAPHY (SPET) STUDY

      Psychopharmacology
    93. SODHI MS; ARRANZ MJ; CURTIS D; BALL DM; SHAM P; ROBERTS GW; PRICE J; COLLIER DA; KERWIN RW
      ASSOCIATION BETWEEN CLOZAPINE RESPONSE AND ALLELIC VARIATION IN THE 5-HT2C RECEPTOR GENE

      NeuroReport
    94. BUSATTO GF; DAVID AS; COSTA DC; ELL PJ; PILOWSKY LS; LUCEY JV; KERWIN RW
      SCHIZOPHRENIC AUDITORY HALLUCINATIONS ARE ASSOCIATED WITH INCREASED REGIONAL CEREBRAL BLOOD-FLOW DURING VERBAL MEMORY ACTIVATION IN A STUDYUSING SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY

      PSYCHIATRY RESEARCH-NEUROIMAGING
    95. GRAY NS; PILOWSKY LS; GRAY JA; KERWIN RW
      LATENT INHIBITION IN DRUG-NAIVE SCHIZOPHRENICS - RELATIONSHIP TO DURATION OF ILLNESS AND DOPAMINE D2 BINDING USING SPET

      Schizophrenia research
    96. BECKWITH JP; MCLAUGHLIN DP; STEFANIS N; EASTWOOD S; HARRISON PJ; KERWIN RW
      EXPRESSION OF DEVELOPMENTALLY SPECIFIC ISOFORMS ON NON-NMDA MESSENGER-RNAS IN THE HIPPOCAMPUS OF SCHIZOPHRENICS

      Schizophrenia research
    97. BECKWITH JP; STEFANIS NC; MCLAUGHLIN DP; KERWIN RW
      THE EXPRESSION OF NMDA RECEPTOR SUBUNITS IN SCHIZOPHRENIC POSTMORTEM HUMAN HIPPOCAMPUS

      Schizophrenia research
    98. KERWIN RW; HARRISON PJ
      LOSS OF NON NMDA RECEPTORS IN MEDIAL TEMPORAL-LOBE - A ROBUST NEUROCHEMICAL FINDING - AUTORADIOGRAPHICAL, GENE-EXPRESSION AND IMMUNOCYTOCHEMICAL FINDINGS

      Schizophrenia research
    99. BUSATTO GF; PILOWSKY LS; COSTA DC; ELL PJ; KERWIN RW
      GABA(A) RECEPTOR CHANGES IN SCHIZOPHRENIA IS ASSESSED USING I-123 IOMAZENIL SINGLE-PHOTON EMISSION TOMOGRAPHY (SPET) - A PRELIMINARY-REPORT

      Schizophrenia research
    100. BUSATTO GF; DAVID AS; COSTA DC; ELL PJ; PILOWSKY LS; LUCEY JV; KERWIN RW
      INCREASED BASAL, GANGLIA BLOOD-FLOW DURING MEMORY ACTIVATION IN SCHIZOPHRENIA, RELATIONSHIP WITH AUDITORY HALLUCINATIONS

      Schizophrenia research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 01:27:42